Shenzhen Bioeasy Biotechnology Co.,Ltd.’s Net Profit Dropped 7.3% in First Half of 2022

Shenzhen Bioeasy Biotechnology Co.,Ltd. (深圳市易瑞生物技术股份有限公司) (300942.SZ) reported a net profit of 151.4 million yuan in the first half of 2022, down 7.3% year-on-year.

Meanwhile, the company posted 474.7 million yuan in revenue, up 43.6% year-on-year.

At the end of the reporting period, it had 1.3 billion yuan in total assets and 250.7 million yuan in total liabilities, with a liability-to-asset ratio of 19.7%.